Galantamine, an isoquinoline alkaloid from Amaryllidaceae, is certainly a well-known example of a drug introduced to the therapeutic strategies in the treatment of the symptomatic Alzheimer’s disease (AD) as an acetylcholinesterase (AChE) inhibitor [2]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.